SilverArc Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
SilverArc Capital Management LLC
CRD #304220
SEC #801-116845
CIK #0001816307, 0001652115
AUM 1,605.5 M (2026-03-30)
Employees 9 (56% Investors, 0% Brokers)
Fees
Minimum
Phone617-250-8431
Address20 Park Plaza
Boston, MA 02116
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
17001360102068034002010201520212027
Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure]
Item 5 - Fees and Compensation

A. Below is a discussion of how the Adviser is compensated in connection with providing advisory
   services to its Clients. The Adviser may enter into different fee arrangements on a client-by-client
   basis. It is critical that all Clients, and investors in the Funds, refer to the applicable Client’s
   governing documents for a complete understanding of how the Adviser and its affiliates are
   compensated for advisory services. The information contained herein is a summary only and is
   qualified in its entirety by each applicable Client’s Governing Documents.

    Management Fees for the Adviser. The Adviser generally receives management fees (the
    “Management Fees”) from the Funds between 1.25% to 2.0% per annum of net asset value
    depending on the class of partnership interests. The Management Fee is payable by a Fund to the
    Adviser or its designee quarterly and in advance, as described in each Fund’s respective governing
    documents, and pro-rated for partial periods. For any Sub-Advisory Client, the Adviser is not
    entitled to receive any management fees or compensation.

    Incentive Allocation for the Adviser. Additionally, the general partner of the Fund, or other affiliate
    of the Adviser, (the “General Partner”) may be eligible to receive an incentive or performance
    allocation from a Fund based on a percentage of net capital appreciation (both realized and
    unrealized) during each yearly measurement period (the “Incentive Allocation”), subject to a high
    water mark. The Adviser expects the Incentive Allocation to be between 15% and 22.5% of net
    capital appreciation of the Fund.

    The compensation described above is the Adviser’s typical compensation rates. However,
    Management Fee and Incentive Allocation rates may be negotiable. The Adviser has the right to
    enter into agreements with one or more Fund investors to waive or modify certain terms of the
    offering of a Fund’s interests, or certain rights and obligations of Fund investors, including
    compensation, otherwise applicable to such interest(s), in each case without notice to the Funds’
    other investors.

    Management Fees for SilverArc Private Capital. The Relying Adviser generally receives a
    Management Fee up to 2% of capital commitments during the investment period. However, the
    Management Fee may be reduced for certain investors in particular circumstances, as set forth in
    the Governing Documents for each respective Fund. This Management Fee is payable quarterly in
    advance by limited partners in the Funds. The Management Fee will cover all ordinary
    administrative and overhead expenses including salaries, rent and office equipment. The precise
    amount of, and the manner and calculation of, the Management Fees for each respective Fund is
    governed and disclosed in the Governing Documents.

    Carried Interest Fees for SilverArc Private Capital. In terms of performance-based fees, 20% to
    30% of the Relying Adviser’s Funds’ net investment proceeds are allocated as “carried interest.”
    However, the carried interest may be reduced for certain investors in particular circumstances, as
    set forth in the Governing Documents for each respective Fund. Carried interest will be subject to
    certain adjustments and reserves as stated in more detail in each of the Relying Adviser’s respective
    Fund Governing Documents. All carried interest are distributed to the General Partner, SilverArc
    Private Capital I, LP.

    In addition, certain limited partners that may qualify as an Early Close Investor (as defined below),
    are eligible for (i) a 10% reduction of the Carried Interest with respect to such Early Close Investor
    and (ii) a 10% reduction of the Management Fee payable by such Early Close Investor.

    An “Early Close Investor” is any limited partner that makes a capital commitment to such Fund
    that is accepted by the general partner on or before November 30th, 2024, subject to the extension
    or early termination of such period in the sole discretion of the general partner (such period, the
    “Early Close Date”); provided, that, a limited partner shall only be treated as an Early Close
    Investor with respect to a capital commitment accepted by the general partner on or before the Early
    Close Date and any subsequent capital commitment by such limited partner shall not be entitled to
    such benefits.

B. The Management Fee and the Incentive Allocation for the Adviser are proportionally adjusted for
   capital contributions or directly deducted from the capital account balances of fee-paying investors
   in the Funds.

    SilverArc Private Capital directly deducts all applicable fees from the respective Funds’ assets. The
    management fees are typically funded with capital contributions drawn for such purpose, but are
    also permitted to be funded with, or withheld from, proceeds from investments. Carried interest
    distributions generally will be distributed from time to time upon the disposition of investments by
    a respective Fund and are distributed in accordance with the terms of the Offering Documents.

C. Each Fund bears its own legal and other organizational expenses incurred in the formation of the
   Fund (the “Organizational Expenses”) up to an aggregate amount agreed upon in the Fund’s
   Governing Documents. In the General Partner’s sole discretion, certain Organizational Expenses
   may be amortized over a period of up to 60 months from the date the Fund commences its
   investment activities. The operating and administrative expenses that are borne by each Fund or
   SMA client are outlined in the applicable LPA or SMA agreement.

    SilverArc Private Capital will mainly be responsible for all expenses incurred by or on behalf of
    SilverArc Private Capital (including, without limitation, organizational costs of SilverArc Private
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure]
Item 7 - Types of Clients

As described in Item 4, the Adviser provides investment advisory services and sub-advisory services
to pooled investment vehicles (i.e., private funds) that are exempt from registration under the
Investment Company Act of 1940, as amended, and SMAs. The offering of interests to investors in the
Funds are not registered under the Securities Act of 1933, as amended (the “Securities Act”), or the
securities laws of any U.S. state or any other jurisdiction. The offering of the Funds’ interests is made
to U.S. persons in accordance with Regulation D promulgated under the Securities Act by the SEC and
to non-U.S. persons in accordance with Regulation S promulgated under the Securities Act by the SEC.
Sector Form 13F Holdings Value ($M)
Magenta Therapeutics Inc 54.9
UNUM Therapeutics Inc 50.6
Celcuity Inc 40.9
Immunome Inc 40.5
Kodiak Sciences Inc 37.8
Nuvalent Inc 36.4
Abivax Sa 33.7
Monte Rosa Therapeutics Inc 32.9
Erasca Inc 30.0
Ascendis Pharma A/S 28.5
View All
Holdings by Sector ($M)
100080060040020002021202320252027
Type Form D Funds Date Sold AUM
VC SilverArc Private Fund I LP [2025-03-27] 17.4 M 21.7 M
Filed 2025-04-29 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
HF SilverArc Capital Alpha Fund II LP [2019-10-16] 178.5 M 881.4 M
Filed 2025-05-02 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF SilverArc Capital Alpha Fund I LP [2019-10-16] 18.3 M 32.2 M
Filed 2025-05-02 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 4 935.3
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 670.2
(n) Other 0 0.0
Total 7 1,605.5
By Discretionary
Discretionary 7 1,605.5
Non-Discretionary 0 0.0
Total 7 1,605.5
By Non-United States Persons
Non-United States Persons 1,121.0
United States Persons 484.5
Total 7 1,605.5
Form D Directors Role # Filings # Firms 2011 - 2026
Sheila Gujrathi Executive Officer 14 2
Devesh Gandhi Executive Officer 4 2
SilverArc Capital LLC Executive Officer 3 2
SilverArc Capital Management LLC Executive Officer 3 2
Andrew Timpson Executive Officer 2 2
None SilverArc Private Capital Management I LP Executive Officer 1 1
David Haimson Executive Officer 1 1
None SilverArc Private Capital I LP Executive Officer 1 1
EDGAR Form CIK 2011 - 2026
13F-NT [0001652115]
13F-HR [0001816307]
SC 13G [0001816307]
Form 13D/13G Filer Form 13D/13G Subject Filed
SilverArc Capital Management LLC Helix Acquisition Corp III [2026-05-13]
SilverArc Capital Management LLC KalVista Pharmaceuticals Inc [2026-05-13]
SilverArc Capital Management LLC NextCure Inc [2026-02-12]
SilverArc Capital Management LLC Avalo Therapeutics Inc [2026-02-10]
SilverArc Capital Management LLC IBIO Inc [2025-11-14]
SilverArc Capital Management LLC Avalo Therapeutics Inc [2025-11-14]
SilverArc Capital Management LLC Fractyl Health Inc [2025-11-14]
SilverArc Capital Management LLC TELA Bio Inc [2025-02-12]
SilverArc Capital Management LLC Elutia Inc [2024-10-15]
SilverArc Capital Management LLC Mersana Therapeutics Inc [2024-02-14]
View All
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEI5493000HOOCC55G9PD79
Comparable Firms State AUM
Pickering Energy Partners LP
TX 1,659.5 M
Compass Group LLC
NY 1,654.6 M
Dorchester Capital Advisors LLC
CA 1,653.0 M
Cordillera Investment Partners LP
CA 1,644.2 M
SONE Capital Management LLC
NY 1,611.8 M
Alpha Square Group S LLC
NY 1,596.3 M
Sentinel Dome Partners LLC
CA 1,592.2 M
Light Street Capital Management LLC
CA 1,571.3 M
Woodson Capital Management LP
CT 1,546.3 M
Zenyth Advisors LLC
NY 1,544.0 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com